Combined Pembrolizumab and Pegylated Liposomal Doxorubicin in Platinum-Resistant Ovarian Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Gynecologic Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Combined Pembrolizumab and Pegylated Liposomal Doxorubicin in Platinum Resistant Ovarian Cancer: A Phase 2 Clinical Trial
Gynecol. Oncol 2020 Aug 05;[EPub Ahead of Print], EK Lee, N Xiong, SC Cheng, WT Barry, RT Penson, PA Konstantinopoulos, MA Hoffman, N Horowitz, DS Dizon, EH Stover, AA Wright, SM Campos, C Krasner, S Morrissey, C Whalen, R Quinn, UA Matulonis, JF LiuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.